La Neve Stephen R.

USNatural personCEO

Insider

La Neve Stephen R.

USNatural personCEO

Transactions

Issuers

Buys / Sells

1/0

Last tx

28 Nov 2025

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
ACCURAY INC	1,064,814	reported	28 Nov 2025	tx 4+3,584,814
Bone Biologics Corp	176,546	reported	16 Feb 2018	tx 6+4,877,218−2,081,191

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
28 Nov 2025	GRANT_AWARD	ACCURAY INC	1,064,814	0.00 USD	deriv
19 Nov 2025	PURCHASE	ACCURAY INC	20,000	0.97 USD
31 Oct 2025	GRANT_AWARD	ACCURAY INC	1,250,000	0.00 USD	deriv
31 Oct 2025	GRANT_AWARD	ACCURAY INC	1,250,000	0.00 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
ACCURAY INC	1,064,814	reported	28 Nov 2025	tx 4+3,584,814
Bone Biologics Corp	176,546	reported	16 Feb 2018	tx 6+4,877,218−2,081,191

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
28 Nov 2025	GRANT_AWARD	ACCURAY INC	1,064,814	0.00 USD	deriv
19 Nov 2025	PURCHASE	ACCURAY INC	20,000	0.97 USD
31 Oct 2025	GRANT_AWARD	ACCURAY INC	1,250,000	0.00 USD	deriv
31 Oct 2025	GRANT_AWARD	ACCURAY INC	1,250,000	0.00 USD